Tixagevimab,Cilgavimab
AstraZeneca
['imab ']
our 1st yr #rheumfellow, , presenting "breakthrough acute covid-19 infection during the us omicron surge following administration of tixagevimab/cilgavimab in immunocompromised patients with rheumatologic disorders" now @ #acr22 #washurheum 
Rheumatology Division at Washington University in St. Louis. @WUDeptMedicine @WUSTL